Generic Name:

Nintedanib

Storage Condition:

Store below 30°C

Packing:

60 Capsules

Mfg / Mkd By:

Boehringer Ingelheim

Doses:


Therapeutic Use:

Idiopathic pulmonary fibrosis

Description:

Introduction of CYENDIV
150MG CAPSULE
:

CYENDIV 150MG
CAPSULE contains Nintedanib which belongs to the group of medicines called
Kinase inhibitors. It is used to manage idiopathic pulmonary fibrosis (IPF),
chronic fibrosing interstitial lung diseases (ILDs) with a progressive
phenotype, slowing the rate of decline in pulmonary function in patients with
systemic sclerosis-associated interstitial lung disease (SSc-ILD). It is used
in combination with docetaxel in adult patients for the management of locally
advanced metastatic or recurrent non-small cell lung cancer (NSCLC) of
adenocarcinoma tumor histology after first line chemotherapy.

Idiopathic
Pulmonary Fibrosis (IPF) is a chronic lung disorder in which the lungs become
scarred and breathing becomes increasingly difficult. Symptoms include
shortness of breath, persistent dry cough, tiredness, loss of appetite, weight
loss, rounded and swollen fingertips (clubbed fingers).

Before taking
CYENDIV 150MG CAPSULE inform your doctor if you have liver, heart or bleeding
problems, history of blood clots or had a recent surgery in stomach. CYENDIV
150MG CAPSULE is not recommended for use in pregnant women unless advised by
your doctor and it is not recommended for use in breastfeeding women as it may
pass through breast milk. Before starting management with CYENDIV 150MG
CAPSULE, your doctor may want you to take several blood tests to understand
your existing condition.

CYENDIV 150MG
CAPSULE should be used with caution in elderly patients (aged 65 years and
above). The most common side effects of taking CYENDIV 150MG CAPSULE are
diarrhoea, nausea, vomiting, stomach pain, loss of appetite, headache, weight
loss and high blood pressure. Consult your doctor if any of the symptom
worsens.

Uses of CYENDIV 150MG CAPSULE:


Manage idiopathic pulmonary fibrosis (IPF)

Manage chronic fibrosing
interstitial lung diseases (ILDs) with a progres

To slow the rate of decline in
pulmonary function in patients with systemic sclerosis- associated interstitial lung disease
(SSc-ILD)

How to use CYENDIV
150MG CAPSULE
:

CYENDIV 150MG
CAPSULE is a tyrosine kinase inhibitor (TKI) which works by blocking the
enzymes in cells of the lungs called tyrosine kinases. Blocking these enzymes
helps to decrease fibrous tissue formation in the lungs, thereby stops the
symptoms of lung disease getting worse.

Our Other Products

View All
Carboplatin

Carboplatin

Generic Name: Carboplatin

Injection
Packaging:45 ml vial
Mfg / Mfd By:Pfizer Ltd
Storage Condition:Store below 30°C
Therapeutic Use:
Cancer
Amgicin (Gemcitabine Injection)

Amgicin (Gemcitabine Injection) 1000 mg

Generic Name: Gemcitabine

Injection
Packaging:1 Vial
Mfg / Mfd By:Adley Ltd
Storage Condition:Store below 30°C
Therapeutic Use:
Bladder cancer Ovarian cancer
Aprecap (Fosaprepitant Dimeglumine)

Aprecap (Fosaprepitant Dimeglumine) 150 mg

Generic Name: Fosaprepitant Dimeglumine

Injection
Packaging:150 mg Vial
Mfg / Mfd By:Glenmark Pharmaceuticals Ltd
Storage Condition:Store in a refrigerator (2° - 8°C). Do not freeze.
Therapeutic Use:
Cancer
Apretero (Aprepitant)

Apretero (Aprepitant) 125 mg + 80 mg

Generic Name: Aprepitant

Capsule
Packaging:1 kit
Mfg / Mfd By:Hetero Healthcare Ltd
Storage Condition:Store below 30°C
Therapeutic Use:
Cancer